Anti-FAK (phospho S732) antibody [EPR26074-44]
- KO Validated
- Recombinant
- RabMAb
- 20ul selling size
- What is this?
Be the first to review this product! Submit a review
|
(0 Publication)
Rabbit Recombinant Monoclonal FAK phospho S732 antibody. Suitable for Dot, WB and reacts with Synthetic peptide - Human, Human, Mouse, Rat samples.
View Alternative Names
FAK, FAK1, PTK2, Focal adhesion kinase 1, FADK 1, Focal adhesion kinase-related nonkinase, Protein phosphatase 1 regulatory subunit 71, Protein-tyrosine kinase 2, p125FAK, pp125FAK, FRNK, PPP1R71
- WB
Supplier Data
Western blot - Anti-FAK (phospho S732) antibody [EPR26074-44] (AB322920)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
In Western blot, ab322920 was shown to bind specifically to FAK (phospho S732). Target of interest was observed at 75-120 kDa in wild-type HEK-293 cell lysates (lane 2) with no signal observed at this size in FAK knockout cell line (lanes 3-4) (lane 3, knockout cell line ab255421 / knockout cell lysate ab263766).
The expression profile/ molecular weight observed is consistent with what has been described in the literature (PMID : 35787638).
The identity of the higher MW band at approximately 250 kDa (in lanes 1-4) is unknown.
In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/200000 dilution.
In Western blot, Anti-FAK antibody - Total protein control (ab40794) staining at 1/1000 dilution.
All lanes:
Western blot - Anti-FAK (phospho S732) antibody [EPR26074-44] (ab322920) at 1/1000 dilution
Lane 1:
Untreated Wild-type HEK-293 (human embryonic kidney epithelial cell) whole cell lysate (untreated membrane) at 20 µg
Lane 2:
Wild-type HEK-293 treated with 100nM Calycin A for 30 minutes whole cell lysate (untreated membrane) at 20 µg
Lane 3:
Untreated FAK knockout HEK-293 whole cell lysate (untreated membrane) at 20 µg
Lane 4:
FAK knockout HEK-293 treated with 100nM Calycin A for 30 minutes whole cell lysate (untreated membrane) at 20 µg
Lane 5:
Untreated Wild-type HEK-293 whole cell lysate (alkaline phosphatase treated membrane) at 20 µg
Lane 6:
Wild-type HEK-293 treated with 100nM Calycin A for 30 minutes whole cell lysate (alkaline phosphatase treated membrane) at 20 µg
Lane 7:
Untreated FAK knockout HEK-293 whole cell lysate (alkaline phosphatase treated membrane) at 20 µg
Lane 8:
FAK knockout HEK-293 treated with 100nM Calycin A for 30 minutes whole cell lysate (alkaline phosphatase treated membrane) at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Observed band size: 75-120 kDa,36 kDa
false
Exposure time: 180s
- WB
Supplier Data
Western blot - Anti-FAK (phospho S732) antibody [EPR26074-44] (AB322920)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
The expression profile/ molecular weight observed is consistent with what has been described in the literature (PMID : 35787638).
The identity of the higher MW band at approximately 250 kDa (in lanes 1-2) is unknown.
In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/200000 dilution.
In Western blot, Anti-FAK antibody - Total protein control (ab40794) staining at 1/1000 dilution.
All lanes:
Western blot - Anti-FAK (phospho S732) antibody [EPR26074-44] (ab322920) at 1/1000 dilution
Lane 1:
Untreated PC-12 (rat adrenal gland pheochromocytoma cell) whole cell lysate (untreated membrane) at 20 µg
Lane 2:
PC-12 treated with 100nM Calycin A for 10 minutes whole cell lysate (untreated membrane) at 20 µg
Lane 3:
Untreated PC-12 whole cell lysate (alkaline phosphatase treated membrane) at 20 µg
Lane 4:
PC-12 treated with 100nM Calycin A for 10 minutes whole cell lysate (alkaline phosphatase treated membrane) at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
false
Exposure time: 15s
- WB
Supplier Data
Western blot - Anti-FAK (phospho S732) antibody [EPR26074-44] (AB322920)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
The expression profile/ molecular weight observed is consistent with what has been described in the literature (PMID : 35787638).
The identity of the higher MW band at approximately 250 kDa (in lanes 1-2) is unknown.
In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/200000 dilution.
In Western blot, Anti-FAK antibody - Total protein control (ab40794) staining at 1/1000 dilution.
All lanes:
Western blot - Anti-FAK (phospho S732) antibody [EPR26074-44] (ab322920) at 1/1000 dilution
Lane 1:
Untreated NIH/3T3 (mouse embryonic fibroblast) whole cell lysate (untreated membrane) at 20 µg
Lane 2:
NIH/3T3 treated with 100nM Calycin A for 30 minutes whole cell lysate (untreated membrane) at 20 µg
Lane 3:
Untreated NIH/3T3 whole cell lysate (alkaline phosphatase treated membrane) at 20 µg
Lane 4:
NIH/3T3 treated with 100nM Calycin A for 30 minutes whole cell lysate (alkaline phosphatase treated membrane) at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
false
Exposure time: 59s
- Dot
Supplier Data
Dot Blot - Anti-FAK (phospho S732) antibody [EPR26074-44] (AB322920)
Dot blot analysis of FAK (phospho S732) using ab322920 at 1000 (0.531 ug/ml) followed by a Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (ab97051) at 1 : 100,000 dilution.
Lane1 : FAK (phospho S732) peptide a
Lane2 : FAK (phospho S732) peptide b
Lane3 : FAK non-phospho peptide c
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
All lanes:
Dot Blot - Anti-FAK (phospho S732) antibody [EPR26074-44] (ab322920) at 1/1000 dilution
Lane 1:
FAK (phospho S732) peptide a
Lane 2:
FAK (phospho S732) peptide b
Lane 3:
FAK non-phospho peptide c
Secondary
All lanes:
Dot Blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
false
Exposure time: 180s
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com